News at the SOGC
April 16, 2014
In response to recent media interest and an article published in the JOGC, the SOGC wants to reassure pregnant women that the combination of doxylamine and pyridoxine is safe as a treatment for nausea and vomiting. The SOGC’s clinical practice guideline on nausea and vomiting in pregnancy is clear – Diclectin is safe.
Health Canada has approved the drug for use in Canada, citing it as one of the most highly tested drugs on the market for pregnant women. In 2013, the US Food and Drug Administration approved this formulation as a Category A drug — adequate and well-controlled studies have failed to demonstrate a risk to the fetus.
April 15, 2014
The SOGC Clinical Practice Guideline on Female Genital Cutting is quite clear that the SOGC condemns this practice, and that FGM and Reinfibulation should NOT be done.
The SOGC, however, DOES NOT condemn the women who have been subjected to FGM; we recognize that these women are often discriminated against, and do require, as every woman does, compassionate care.
March 27, 2014
Emergency contraceptive pills, also known as the “morning after” pill, will soon carry new warnings about reduced effectiveness in women weighing over 165 pounds.
Health Canada has asked companies to add new warnings to product packages advising that these pills are less effective in women weighing 165 to 176 pounds (75-80 kg), and are not effective in women over 176 pounds (80 kg). Women who weigh 165 pounds or more are advised to ask a health professional, such as a doctor or pharmacist, for advice on alternative methods of emergency contraception.
Clinical Practice Guidelines